Skip to main content

Table 3 Combination rates of chemotherapy and these regimens

From: Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005

  T1a T1b T2
Combination rate (%) 23† 22†† 60
Regimen (n)
 Low dose CDDP (daily) 0 1 6
 Low dose CDDP/5FU (daily) 0 1 2
 High dose CDDP/5FU 9 5 17
 Carboplatin (daily) 1 0 0
 Carboplatin (weekly) 4 1 12
 CDDP/5FU/DTX 0 0 5
 DTX (Docetaxel) 1 0 2
 UFT (oral antidrug) 12 5 6
 TS-1 (oral antidrug) 1 1 0
  1. † T1a vs. T2: p < 0.001; †† T1b vs. T2: p < 0.001.